Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125261003 | 12526100 | 3 | F | 20160713 | 20160705 | 20160808 | PER | US-PFIZER INC-2016305905 | PFIZER | 71.00 | YR | F | Y | 64.00000 | KG | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125261003 | 12526100 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0.5 G, 2X/WEEK | Y | 20216 | .5 | G | VAGINAL CREAM | BIW | ||||||
| 125261003 | 12526100 | 2 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Y | 20216 | VAGINAL CREAM | ||||||||||
| 125261003 | 12526100 | 3 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Y | 20216 | VAGINAL CREAM | ||||||||||
| 125261003 | 12526100 | 4 | C | SKELAXIN | METAXALONE | 1 | 800 MG, UNK | 0 | 800 | MG | TABLET | ||||||||
| 125261003 | 12526100 | 5 | C | MOBIC | MELOXICAM | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 125261003 | 12526100 | 6 | C | CLOBETASOL PROPIONATE. | CLOBETASOL PROPIONATE | 1 | UNK | 0 | CREAM | ||||||||||
| 125261003 | 12526100 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125261003 | 12526100 | 1 | Blood oestrogen decreased |
| 125261003 | 12526100 | 2 | Vulvovaginal dryness |
| 125261003 | 12526100 | 3 | Dyspareunia |
| 125261003 | 12526100 | 4 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125261003 | 12526100 | Burning sensation | |
| 125261003 | 12526100 | Drug hypersensitivity | |
| 125261003 | 12526100 | Erythema | |
| 125261003 | 12526100 | Pruritus | |
| 125261003 | 12526100 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |